Moderna to Ask FDA for Emergency Use Authorization of Its “Up to 44% Effective” COVID-19 Vaccine for Kids as Young as 6 Months
Moderna’s two-dose COVID-19 vaccine was 44% effective at preventing infection from Omicron in children 6 months to under 2 years old and roughly 38% effective